U.S. Physical Therapy, Inc. - 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2002. U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics providing post-operative care and treatment for orthopedic and sports-related injuries. As of June 30, 2002, the Company operated 176 clinics across 31 states and managed six additional third-party facilities.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2002 | Six Months Ended June 30, 2001 |
|---|---|---|
| Net Revenues | $46,301,000 | $38,796,000 |
| Net Income | $4,412,000 | $3,299,000 |
| Diluted EPS | $0.34 | $0.26 |
| Operating Cash Flow | $10,196,000 | $7,848,000 |
| Cash & Equivalents (End of Period) | $14,446,000 | $6,612,000 |
| Convertible Debt Outstanding | $2,333,000 | $3,000,000 |
| Current Ratio | 10.33:1 | 6.03:1 (Dec 31, 2001) |
Material Changes vs. Prior Period
- Revenue Growth: Net patient revenues increased 20% year-over-year for the six-month period, driven by an 18% increase in total patient visits (493,000 vs. 419,000). Growth was attributed to 30 new clinics (contributing 36% of the revenue increase) and higher visit volumes in mature clinics.
- Profitability: Net income rose 34% to $4.41 million. Operating income increased to $9.89 million, aided by a decrease in clinic operating costs as a percentage of revenue (67% vs. 68% prior year).
- Debt Reduction: The Company converted $667,000 of Series C Convertible Subordinated Notes into common stock during the quarter. Total debt-to-equity ratio improved to 0.06 from 0.14 at year-end 2001.
- Acquisitions: The Company purchased minority interests in several clinic partnerships in Michigan, Pennsylvania, and Texas, totaling approximately $1.3 million in cash and stock consideration.
Outlook, Risks, and Management Commentary
- Guidance: Management aims to open between 35 and 40 new clinics in 2002. New clinics are expected to incur initial operating losses before becoming profitable over 2-3 years.
- Capital Allocation: In July 2002 (subsequent to the reporting period), the Company repurchased 400,000 shares of common stock for $5.75 million. The Board has authorized up to 1,000,000 shares for repurchase.
- Regulatory Risk: Medicare reimbursement for outpatient therapy is subject to a $1,500 annual cap per patient. A moratorium on this cap is currently in effect through December 31, 2002. Management does not anticipate a material impact if the cap becomes effective in 2003, as they generally do not treat long-term complicated cases.
- Liquidity: The Company maintains strong liquidity with $14.4 million in cash, sufficient to fund operations and expansion through 2002 without external financing.
Investor Verification Checklist
- Verify the sustainability of the 20% revenue growth rate given the mild winter weather impact on injury volumes in the prior year.
- Monitor the conversion of remaining $2.33 million in Convertible Subordinated Notes due in 2004.
- Assess the impact of the $5.75 million stock repurchase on future capital available for clinic expansion.
- Review the timeline for the expiration of the Medicare reimbursement moratorium in late 2002.
- Confirm the integration and profitability timeline of the 30 new clinics opened since mid-2001.